312
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant

, MD, MSc, , MD, , MD, , MD, , MD, PhD & , MD, PhD
Pages 447-454 | Received 13 Jul 2015, Accepted 14 Dec 2015, Published online: 22 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Nitin Kumar Menia, Sashwanthi Mohan & Aniruddha Agarwal. (2023) Intravitreal immunotherapy in non-infectious uveitis: an update. Expert Review of Clinical Pharmacology 0:0, pages 1-18.
Read now
Kamal Kishore, Pooja V Bhat, Pradeep Venkatesh & Cecilia C Canizela. (2022) Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review. Clinical Ophthalmology 16, pages 1019-1045.
Read now
Thorsteinn Loftsson. (2022) Topical drug delivery to the retina: obstacles and routes to success. Expert Opinion on Drug Delivery 19:1, pages 9-21.
Read now
Kyle A. Kirkland, Sami H. Uwaydat, Mohammad Z. Siddiqui, John R. Chancellor, Mohamed K. Soliman, Shree Kurup & Ahmed B. Sallam. (2021) Outcome of Intravitreal Dexamethasone Implant Use in Uveitic Eyes Undergoing Pars Plana Vitrectomy Surgery. Ocular Immunology and Inflammation 29:6, pages 1126-1131.
Read now

Articles from other publishers (8)

Shipei Fan, Xing-yu Shi, Chao-fu Zhao, Zhen Chen, Jia Ying, Song-ping Yu, Jun Li & Xia Li. (2023) Efficacy and safety of single-dose intravitreal dexamethasone implant in non-infectious uveitic macular edema: A systematic review and meta-analysis. Frontiers in Medicine 10.
Crossref
Shun Zeng, Li Yang, Feng Bai, Tao Liu & Xiaoli Liu. (2022) Intravitreal dexamethasone implant for noninfectious uveitis in Chinese patients. International Ophthalmology 42:7, pages 2063-2069.
Crossref
Valeria Albano, Silvana Guerriero, Claudio Furino, Giancarlo Sborgia, Alessandra Sborgia, Rosanna Dammacco, Francesco Boscia & Giovanni Alessio. (2022) Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography. International Ophthalmology 42:11, pages 3285-3293.
Crossref
TarekR Elhamaky. (2022) Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis. Indian Journal of Ophthalmology 70:7, pages 2465.
Crossref
Ian C. Han, D. Brice Critser, Alec L. Amram & James C. Folk. (2020) RETAINED, NONDISSOLVING, TUBULAR FOREIGN BODIES IN THE VITREOUS CAVITY AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANTATION. Retina 40:11, pages 2221-2225.
Crossref
K. V. Sokolov & A. K. Smirnov. (2020) Intravitreal Dexamethasone implant injection: Analysis of clinical efficacy and subjective satisfaction of patients with post-thrombotic macular edema. Pacific Medical Journal:3, pages 93-94.
Crossref
Horace Massa, Panagiotis Georgoudis & Georgios D Panos. (2019) Dexamethasone intravitreal implant (OZURDEX ® ) for macular edema secondary to noninfectious uveitis: a review of the literature . Therapeutic Delivery 10:6, pages 343-351.
Crossref
KunalKaushik Shah, ParthopratimDutta Majumder & Jyotirmay Biswas. (2018) Intravitreal therapeutic agents in noninfectious uveitic macular edema. Indian Journal of Ophthalmology 66:8, pages 1060.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.